📊 OABIW Key Takeaways
Is OmniAb, Inc. (OABIW) a Good Investment?
OmniAb is burning cash at an unsustainable rate (-$36.5M operating CF) while revenue contracts 29.3% YoY, generating massive operating losses (-369.5% margin). Despite a fortress balance sheet, the company's core business model is fundamentally broken with negative cash flow and deteriorating top-line growth indicating imminent financial distress.
OmniAb shows strong liquidity and no debt, but revenue contracted sharply while losses and cash burn remain substantial. Without clear evidence of improving unit economics or scaling revenue, the company may need additional financing to sustain operations, pressuring fundamentals. Improvement in revenue trajectory and operating efficiency is required before a more positive view is warranted.
Why Buy OmniAb, Inc. Stock? OABIW Key Strengths
- Strong balance sheet with zero long-term debt (Debt/Equity 0.00x)
- Excellent liquidity position with 4.02x current ratio and $25.5M cash
- Substantial stockholders' equity of $267.0M provides solvency buffer
- Debt-free balance sheet with strong liquidity (current ratio ~4x)
- Large equity base relative to liabilities, providing financial cushion
- Capital-light model (minimal capex) enabling potential operating leverage if revenue scales
OABIW Stock Risks: OmniAb, Inc. Investment Risks
- Revenue declining 29.3% YoY with only $18.7M top-line
- Operating cash flow negative at -$36.5M indicating business is destroying value
- Extreme operating margin of -369.5% and net margin of -347.0% unsustainable
- At current burn rate, cash runway limited to <9 months
- Operating losses of $69.0M dwarf revenue, suggesting fundamental business model failure
- Sharp revenue decline (-29% YoY) alongside extremely negative margins indicates weak operating performance
- High cash burn (OCF -$36.5M; FCF -$37.0M) versus $25.5M cash implies limited runway and potential dilution
- Execution risk on pipeline/partner monetization; continued delays prolong losses
Key Metrics to Watch
- Operating cash flow trend and cash runway remaining
- Revenue stabilization or continued decline
- Path to profitability and cost restructuring measures
- Quarterly cash burn rate and balance sheet depletion
- Revenue growth (YoY and QoQ)
- Operating cash flow and cash runway (cash/OCF)
OmniAb, Inc. (OABIW) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 4.02x current ratio provides a solid financial cushion.
OABIW Profit Margin, ROE & Profitability Analysis
OABIW vs Healthcare Sector: How OmniAb, Inc. Compares
How OmniAb, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is OmniAb, Inc. Stock Overvalued? OABIW Valuation Analysis 2026
Based on fundamental analysis, OmniAb, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
OmniAb, Inc. Balance Sheet: OABIW Debt, Cash & Liquidity
OABIW Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: OmniAb, Inc.'s revenue has declined by 55% over the 5-year period, indicating business contraction. The most recent EPS of $-0.61 indicates the company is currently unprofitable.
OABIW Revenue Growth, EPS Growth & YoY Performance
OABIW Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $2.2M | -$13.6M | $-0.14 |
| Q2 2025 | $3.9M | -$13.6M | $-0.13 |
| Q1 2025 | $3.8M | -$18.2M | $-0.17 |
| Q3 2024 | $4.2M | -$6.1M | $-0.16 |
| Q2 2024 | $6.9M | -$6.1M | $-0.13 |
| Q1 2024 | $3.8M | -$6.1M | $-0.06 |
| Q3 2023 | $5.5M | -$6.1M | $-0.15 |
| Q2 2023 | $6.9M | -$6.1M | $-0.12 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
OmniAb, Inc. Dividends, Buybacks & Capital Allocation
OABIW SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for OmniAb, Inc. (CIK: 0001846253)
📋 Recent SEC Filings
❓ Frequently Asked Questions about OABIW
What is the AI rating for OABIW?
OmniAb, Inc. (OABIW) has a Combined AI Rating of SELL from Claude (STRONG SELL) and ChatGPT (SELL) with 78% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are OABIW's key strengths?
Claude: Strong balance sheet with zero long-term debt (Debt/Equity 0.00x). Excellent liquidity position with 4.02x current ratio and $25.5M cash. ChatGPT: Debt-free balance sheet with strong liquidity (current ratio ~4x). Large equity base relative to liabilities, providing financial cushion.
What are the risks of investing in OABIW?
Claude: Revenue declining 29.3% YoY with only $18.7M top-line. Operating cash flow negative at -$36.5M indicating business is destroying value. ChatGPT: Sharp revenue decline (-29% YoY) alongside extremely negative margins indicates weak operating performance. High cash burn (OCF -$36.5M; FCF -$37.0M) versus $25.5M cash implies limited runway and potential dilution.
What is OABIW's revenue and growth?
OmniAb, Inc. reported revenue of $18.7M.
Does OABIW pay dividends?
OmniAb, Inc. does not currently pay dividends.
Where can I find OABIW SEC filings?
Official SEC filings for OmniAb, Inc. (CIK: 0001846253) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is OABIW's EPS?
OmniAb, Inc. has a diluted EPS of $-0.57.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is OABIW a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, OmniAb, Inc. has a SELL rating with 78% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is OABIW stock overvalued or undervalued?
Valuation metrics for OABIW: ROE of -24.3% (sector avg: 15%), net margin of -347.0% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy OABIW stock in 2026?
Our dual AI analysis gives OmniAb, Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is OABIW's free cash flow?
OmniAb, Inc.'s operating cash flow is $-36.5M, with capital expenditures of $565.0K. FCF margin is -198.3%.
How does OABIW compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -347.0% (avg: 12%), ROE -24.3% (avg: 15%), current ratio 4.02 (avg: 2).